FLORHAM PARK, N.J., March 16, 2023 (WORLD WIRE SERVICE)– PDS Biotechnology Company PDSB, a clinical-stage immunotherapy business creating an expanding pipe of targeted immunotherapies for cancer cells as well as contagious illness, today revealed that the Firm will certainly launch economic outcomes for the 4th quarter of 2022 on Tuesday, March 28, 2023, prior to the marketplace opens up. Adhering to the launch, monitoring will certainly organize a teleconference to examine the economic outcomes as well as give a service upgrade.
Tuesday, March 28, 2023, 8:00 AM EDT
Residential: 877-407-3088
International: 201-389-0927
Meeting ID: 13736455
Webcast: PDS Biotech Earnings Webcast
After the real-time webcast, the occasion will certainly be archived on PDS Biotech’s web site for 6 months.
Concerning PDS Biotechnology
PDS Biotech is a clinical-stage immunotherapy business creating an expanding pipe of targeted cancer cells as well as contagious illness immunotherapies based upon our exclusive Versamune ®, Versamune ® plus PDS0301, as well as Infectimune ™ T cell-activating systems. Our team believe our targeted immunotherapies have the prospective to get over the restrictions of existing immunotherapy techniques with the activation of the best kind, amount as well as effectiveness of T cells. To day, our lead medical prospect, PDS0101, has actually shown the capability to minimize growths as well as support illness in mix with accepted as well as investigational rehabs in people with a wide variety of HPV16-associated cancers cells. Our Infectimune ™ based injections have actually likewise shown the prospective to cause not just durable as well as resilient reducing the effects of antibody feedbacks, however likewise effective T cell feedbacks, consisting of resilient memory T cell feedbacks in pre-clinical researches to day. To get more information, please browse through www.pdsbiotech.com or follow us on Twitter at @PDSBiotech.
Financier Get In Touches With:
Deanne Randolph
PDS Biotech
Phone: +1 (908) 517-3613
Email: [email protected]
Abundant Cockrell
CG Resources
Phone: +1 (404) 736-3838
Email: [email protected]
Media Contacts:
Tiberend Strategic Advisors, Inc.
Dave Schemelia
Phone: +1 (609) 468-9325
[email protected]
Costs Borden
Phone: +1 (732) 910-1620
[email protected]
